Sangamo Therapeutics (SGMOQ) EPS (Basic) (2010 - 2025)
Sangamo Therapeutics (SGMOQ) posted EPS (Basic) of -$0.13 for Q4 2025, down 16.34% on a QoQ basis from -$0.11 in Q3 2025, and down 15.13% year-over-year from -$0.16 in Q4 2024.
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) EPS (Basic) (2010 - 2025) Analysis & Trends
Sangamo Therapeutics has reported EPS (Basic) for 16 years, with the latest figure at -$0.13 in Q4 2025.
- On a quarterly basis, EPS (Basic) fell 15.13% year-over-year to -$0.13 in Q4 2025; TTM through Dec 2025 was -$0.44, a 10.82% increase from a year earlier, with the FY2025 full-year figure at -$0.44, up 9.65% from the prior year.
- EPS (Basic) was -$0.13 for Q4 2025 at Sangamo Therapeutics, down from -$0.11 in the prior quarter.
- The five-year high for EPS (Basic) was $0.13 in Q1 2023, with the low at -$0.66 in Q2 2023.
- Average EPS (Basic) over 5 years is -$0.25, with a median of -$0.28 recorded in 2022.
- The sharpest annual moves came in 2021 and 2023: EPS (Basic) slumped 2968.83% in 2021, then soared 141.65% in 2023.
- Over 5 years, EPS (Basic) stood at -$0.26 in 2021, then slipped by 29.85% to -$0.34 in 2022, then declined by 2.7% to -$0.35 in 2023, then surged by 66.44% to -$0.12 in 2024, then slipped by 15.13% to -$0.13 in 2025.
- The last three EPS (Basic) figures came in at -$0.13 (Q4 2025), -$0.11 (Q3 2025), and -$0.08 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.12 Bn | 9.27 Bn | 112.79 Mn | 1.85 |
| 2 | CRISPR Therapeutics AG | 5.23 Bn | 5.23 Bn | - | -0.94 |
| 3 | Iovance Biotherapeutics | 3.86 Bn | 3.56 Bn | 55.72 Mn | -0.11 |
| 4 | Legend Biotech | 3.67 Bn | 2.71 Bn | 251.50 Mn | 0.42 |
| 5 | uniQure | 3.08 Bn | 3.08 Bn | 5.49 Mn | -1.22 |
| 6 | Beam Therapeutics | 2.67 Bn | 2.67 Bn | - | -1.18 |
| 7 | Precigen | 2.43 Bn | 2.43 Bn | 52.17 Mn | 0.06 |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.54 Bn | 251.87 Mn | -0.05 |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 0.04 |
| 10 | Sangamo Therapeutics | 43.15 Mn | 22.20 Mn | - | -0.13 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -0.13 |
| Sep 30, 2025 | -0.11 |
| Jun 30, 2025 | -0.08 |
| Mar 31, 2025 | -0.14 |
| Dec 31, 2024 | -0.12 |
| Sep 30, 2024 | 0.05 |
| Jun 30, 2024 | -0.18 |
| Mar 31, 2024 | -0.27 |
| Dec 31, 2023 | -0.35 |
| Sep 30, 2023 | -0.59 |
| Jun 30, 2023 | -0.66 |
| Mar 31, 2023 | 0.13 |
| Dec 31, 2022 | -0.34 |
| Sep 30, 2022 | -0.34 |
| Jun 30, 2022 | -0.29 |
| Mar 31, 2022 | -0.30 |
| Dec 31, 2021 | -0.26 |
| Sep 30, 2021 | -0.33 |
| Jun 30, 2021 | -0.33 |
| Mar 31, 2021 | -0.32 |